MWG Management Ltd. - Q2 2023 holdings

$165 Million is the total value of MWG Management Ltd.'s 3 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
BEAM  BEAM THERAPEUTICS INC$74,937,603
+4.3%
2,346,9340.0%45.33%
-10.4%
LYEL  LYELL IMMUNOPHARMA INC$64,116,216
+34.7%
20,162,3320.0%38.79%
+15.8%
SellPRIME MEDICINE INC$26,255,877
+16.3%
1,792,210
-2.4%
15.88%
-0.1%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Milky Way Investments Group Ltd. #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEAM THERAPEUTICS INC12Q3 202394.5%
LYELL IMMUNOPHARMA INC10Q3 202359.1%
PRIME MEDICINE INC4Q3 202317.4%
VIR BIOTECHNOLOGY INC3Q2 20218.1%
RELX PLC2Q3 202137.3%
Illumina Inc1Q3 202116.6%

View MWG Management Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View MWG Management Ltd.'s complete filings history.

Compare quarters

Export MWG Management Ltd.'s holdings